Amyris Inc. (NASDAQ: AMRS) stock jumped 15.92% on Monday to $1.82 against a previous-day closing price of $1.57. With 9.76 million shares changed hands, the volume of the stock remained heavier than its average volume of 6.43 million shares. During the session, the Specialty Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $1.8550 whereas the lowest price it dropped to was $1.5900. The 52-week range on AMRS shows that it touched its highest point at $5.30 and its lowest point at $1.25 during that stretch. It currently has a 1-year price target of $7.02. Beta for the stock currently stands at 1.04.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AMRS was up-trending over the past week, with a rise of 13.75%, but this was down by -8.08% over a month. Three-month performance dropped to -19.29% while six-month performance fell -4.71%. The stock lost -59.47% in the past year, while it has gained 18.95% so far this year. A look at the trailing 12-month EPS for AMRS yields -1.07 with Next year EPS estimates of -0.65. For the next quarter, that number is -0.27. This implies an EPS growth rate of 50.80% for this year and 56.10% for next year. EPS is expected to grow by 30.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 31.50%.
Float and Shares Shorts:
At present, 322.29 million AMRS shares are outstanding with a float of 233.91 million shares on hand for trading. On Oct 13, 2022, short shares totaled 45.66 million, which was 14.05% higher than short shares on Sep 14, 2022. In addition to Mr. John G. Melo as the firm’s Pres, CEO & Director, Mr. Hermanus Kieftenbeld serves as its CFO & Chief Admin. Officer.
Through their ownership of 45.94% of AMRS’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 47.67% of AMRS, in contrast to 24.85% held by mutual funds. Shares owned by individuals account for 15.25%. As the largest shareholder in AMRS with 6.06% of the stake, Heights Capital Management, Inc. holds 20,000,000 shares worth 20,000,000. A second-largest stockholder of AMRS, The Vanguard Group, Inc., holds 19,454,695 shares, controlling over 5.89% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in AMRS, holding 11,796,761 shares or 3.57% stake. With a 2.04% stake in AMRS, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 6,736,712 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 1.78% of AMRS stock, is the second-largest Mutual Fund holder. It holds 5,872,689 shares valued at 8.99 million. Edmond de Rothschild Fund – Big D holds 1.38% of the stake in AMRS, owning 4,563,800 shares worth 6.98 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AMRS since 6 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AMRS analysts setting a high price target of $6.00 and a low target of $2.00, the average target price over the next 12 months is $3.28. Based on these targets, AMRS could surge 229.67% to reach the target high and rise by 9.89% to reach the target low. Reaching the average price target will result in a growth of 80.22% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. AMRS will report FY 2022 earnings on 02/27/2024. Analysts have provided yearly estimates in a range of -$1.37 being high and -$1.44 being low. For AMRS, this leads to a yearly average estimate of -$1.40. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Amyris Inc. surprised analysts by -$0.42 when it reported -$0.50 EPS against a consensus estimate of -$0.08. The surprise factor in the prior quarter was -$0.05. Based on analyst estimates, the high estimate for the next quarter is -$0.18 and the low estimate is -$0.28. The average estimate for the next quarter is thus -$0.24.
Summary of Insider Activity:
Insiders traded AMRS stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 13,333,334 shares were bought while 0 shares were sold. The number of buy transactions has increased to 18 while that of sell transactions has risen to 19 over the past year. The total number of shares bought during that period was 14,359,772 while 1,459,962 shares were sold.